1-4 of 4
Nicholas J. Goulden, MD
Close
Sort by
Journal Articles

Stem Cells in T-ALL Have a Primitive CD133 + /CD34 + /CD7 - Phenotype.

Charlotte V. Cox, BSc, Roger S. Evely, MD, Nicholas J. Goulden, MD, Allison Blair, PhD
Journal: Blood
Blood (2004) 104 (11): 1885.
https://doi.org/10.1182/blood.V104.11.1885.1885
Published: 2004
Journal Articles

CMV Specific Immunotherapy: How Many Patients Will Benefit?.

Russell J. Garland, PhD, Paraskevi Diamanti, PhD, Samantha E. West, PhD, Ann Green, MSc, David Carrington, PhD, Sarah J. Groves, BSc, Kerri L. Winship, BSc, Stephen P. Robinson, MD, Anthony Oakhill, MD, Jacqueline M. Cornish, MD, Derwood H. Pamphilon, MD, David I. Marks, MD, Nicholas J. Goulden, MD, Allison G. Blair, PhD, Colin G. Steward, MD
Journal: Blood
Blood (2004) 104 (11): 2244.
https://doi.org/10.1182/blood.V104.11.2244.2244
Published: 2004
Journal Articles

CD133 Expression on ALL Progenitor Cells: Further Evidence for a Hierarchy within the Leukaemic Clone.

Charlotte V. Cox, BSc, Roger S. Evely, MD, Nicholas J. Goulden, MD, Allison Blair, PhD
Journal: Blood
Blood (2004) 104 (11): 523.
https://doi.org/10.1182/blood.V104.11.523.523
Published: 2004
Journal Articles

Intensified Conditioning for Children Undergoing BMT for First Bone Marrow Relapse of Acute Lymphoblastic Leukaemia.

John Moppett, MD PhD, Jerry Hancock, PhD, Christopher J.C. Knechtli, MD PhD, Anthony Oakhill, MD, Nicholas J. Goulden, MD PhD
Journal: Blood
Blood (2004) 104 (11): 5169.
https://doi.org/10.1182/blood.V104.11.5169.5169
Published: 2004